Item 1.01. Entry into a Material Definitive Agreement.
On December 30, 2022, BIOLASE, Inc., a Delaware corporation (the "Company"),
entered into the Tenth Amendment to Credit Agreement (the "Tenth Amendment")
with SWK Funding LLC ("SWK"), in connection with that certain Credit Agreement
(the "Credit Agreement"), by and among the Company, SWK, and the lender parties
thereto. The Tenth Amendment amends the Credit Agreement by reducing the
required minimum consolidated unencumbered liquid assets from $3,000,000 to
$2,500,000 and removing the conditional minimum last twelve months aggregate
revenue and Earnings Before Interest, Taxes, Depreciation and Amortization
("EBITDA") as of the end of the twelve month period ending December 31, 2022.
The Tenth Amendment contains representations, warranties, covenants, releases,
and conditions customary for a credit agreement amendment of this type.
The foregoing summary of the Tenth Amendment does not purport to be complete and
is qualified in their entirety by reference to the Tenth Amendment, a copy of
which is attached hereto as Exhibit 10.1, which is incorporated herein by
reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
No. Description
10.1 Tenth Amendment to Credit Agreement, dated as of December 30, 2022,
by and among BIOLASE, INC., each of the Lenders, and SWK FUNDING LLC,
in its capacity as administrative agent for the other Lenders
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document)
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses